Regulation of AMP-activated protein kinase activity by G-protein coupled receptors: potential utility in treatment of diabetes and heart disease.
about
AMPK in the brain: its roles in energy balance and neuroprotectionShikonin increases glucose uptake in skeletal muscle cells and improves plasma glucose levels in diabetic Goto-Kakizaki ratsGPR40 agonist ameliorates liver X receptor-induced lipid accumulation in liver by activating AMPK pathwayInteraction between age and obesity on cardiomyocyte contractile function: role of leptin and stress signaling.Mechanism and role of high density lipoprotein-induced activation of AMP-activated protein kinase in endothelial cells.Involvement of transducer of regulated cAMP response element-binding protein activity on corticotropin releasing hormone transcription.Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice.Concerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin IIActivation of distinct P2Y receptor subtypes stimulates insulin secretion in MIN6 mouse pancreatic beta cells.Effects of controlled-release alpha lipoic acid in lean, nondiabetic patients with polycystic ovary syndrome.G protein-coupled receptors and the regulation of autophagy.Adenosine monophosphate-activated kinase alpha1 promotes endothelial barrier repair.Angiotensin II activates AMPK for execution of apoptosis through energy-dependent and -independent mechanismsN-cadherin coordinates AMP kinase-mediated lung vascular repair.AMP-activated protein kinase as regulator of P2Y(6) receptor-induced insulin secretion in mouse pancreatic β-cellsGenetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathyAngiotensin II Causes Apoptosis of Adult Hippocampal Neural Stem Cells and Memory Impairment Through the Action on AMPK-PGC1α Signaling in Heart Failure.20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol suppresses UV-Induced MMP-1 expression through AMPK-mediated mTOR inhibition as a downstream of the PKA-LKB1 pathway.Cells lacking the fumarase tumor suppressor are protected from apoptosis through a hypoxia-inducible factor-independent, AMPK-dependent mechanism.5'-AMP-activated protein kinase plays an essential role in geniposide-regulated glucose-stimulated insulin secretion in rat pancreatic INS-1 β cells.Apigenin, a chemopreventive bioflavonoid, induces AMP-activated protein kinase activation in human keratinocytes.Melanocortin-4 receptor activation promotes insulin-stimulated mTOR signaling.RhGLP-1 (7-36) protects diabetic rats against cerebral ischemia-reperfusion injury via up-regulating expression of Nrf2/HO-1 and increasing the activities of SOD.Acute regulation of 5'-AMP-activated protein kinase by long-chain fatty acid, glucose and insulin in rat primary adipocytes.Isoproterenol stimulates 5'-AMP-activated protein kinase and fatty acid oxidation in neonatal hearts.Rosiglitazone decreases fasting plasma peptide YY3-36 in type 2 diabetic women: a possible role in weight gain?Inactivation of the AMP-activated protein kinase by glucose in cardiac myocytes: a role for the pentose phosphate pathway.5'-AMP-activated protein kinase is inactivated by adrenergic signalling in adult cardiac myocytes.
P2860
Q24629417-71A9CA4D-D098-49BC-A85E-776417451F53Q28479326-42E10D35-19ED-4F72-AB71-00C000FE50D2Q28834044-912B7FF3-389B-4BEA-9DDB-B73E0CBF24BEQ33556995-F3C1C9EF-A8C4-4DEA-87DA-4588AFB17497Q33717436-33F34914-8D02-4F58-B27F-178D976BF33FQ33735555-9AC30426-735A-4351-88C6-8455ADA9DC78Q33750765-13B406D4-3467-4AB2-B04F-255661CD826EQ33769656-B675E30A-44A1-4429-85BB-4B800D46C40EQ33828185-303F02D3-E878-4DAB-A66D-918C1FCC95E4Q33828251-34ACB191-54CA-47D0-B5E1-7885DCE27A0CQ33847091-3610051D-34A0-4BAA-B18D-9696AE91BC42Q35225087-D0DD04D9-19F5-44DE-8B72-E5F682907CFDQ35543598-1A932293-A927-4A4F-AF5F-2BB099235138Q36422628-5A86E2D2-4162-4807-A5D9-67ABE5F08F7FQ36674463-DBE1596F-CA25-494C-A2CB-7D38FEA0761EQ37174951-96C7F749-E371-495D-9B50-96D0AA8C6017Q38937856-0BEFBE46-B46D-40DD-ADD5-5C761090068FQ38995606-875F3E18-66EF-4D26-84C6-87E8A5C2F112Q39340083-A11BDA0E-3F9C-4AC8-B6EA-5D58156F5A8EQ39413477-A39EB773-73D3-40D3-BE17-F4BE8F3B6EF5Q39549235-BA7BBC0A-101B-4503-9DAB-7056120C7957Q39684197-6B652C43-D642-43AF-B1A7-C2720BC09981Q41636096-6770A296-A395-4C0E-A37A-C1BD7A451FE7Q42410970-DCA05619-BA2E-420E-95BF-ED132E4EF33AQ42959174-D847DA47-25D7-4452-A8E2-7ABBDEA17252Q47342804-82653289-A1AD-4B2B-8009-4229F4F021F3Q53214524-18D544B8-300D-4476-840A-94B4FFBDA71AQ53225075-17D9EEB4-FD05-4413-B189-CDF9F78248E0
P2860
Regulation of AMP-activated protein kinase activity by G-protein coupled receptors: potential utility in treatment of diabetes and heart disease.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Regulation of AMP-activated pr ...... of diabetes and heart disease.
@ast
Regulation of AMP-activated pr ...... of diabetes and heart disease.
@en
Regulation of AMP-activated pr ...... of diabetes and heart disease.
@nl
type
label
Regulation of AMP-activated pr ...... of diabetes and heart disease.
@ast
Regulation of AMP-activated pr ...... of diabetes and heart disease.
@en
Regulation of AMP-activated pr ...... of diabetes and heart disease.
@nl
prefLabel
Regulation of AMP-activated pr ...... of diabetes and heart disease.
@ast
Regulation of AMP-activated pr ...... of diabetes and heart disease.
@en
Regulation of AMP-activated pr ...... of diabetes and heart disease.
@nl
P2093
P1476
Regulation of AMP-activated pr ...... of diabetes and heart disease.
@en
P2093
Dana S Hutchinson
Roger J Summers
Tore Bengtsson
P304
P356
10.1016/J.PHARMTHERA.2008.05.008
P577
2008-06-17T00:00:00Z